A regenerative medicine company focused on developing, manufacturing and commercializing product solutions for the advanced wound care, surgical, and sports medicine markets in the U.S. is among the three biotech stocks highlighted in today’s article that analysts believe have the potential to rally by more than 45% in the next 12 months. For these three stocks, CLICK HERE.
3 Biotech Stocks For 45%+ Gains
